AgingResearch.NewsJoin free

Guangdong Raynovent Biotech

CompanyROR

Trials

  • NCT07362030

    Phase 1, Active, not recruiting, 32 people, 23 Jan 2026

  • NCT07139548

    Phase 3, Not yet recruiting, 600 people, 24 Aug 2025

  • NCT06031454

    Phase 1, Completed, 56 people, 11 Sept 2023

  • NCT05954624

    Phase 1, Completed, 49 people, 20 Jul 2023

Papers